Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora Cannabis is a leading Canada-based licensed producer of medical and consumer cannabis, operating across Canada and internationally, with a proven track record in high-margin, regulated medical cannabis markets. The company recorded a record C$68.1 million in global medical cannabis net revenue in Q3 FY25, a 51% year-over-year increase, driven by international expansion and a robust product pipeline. Aurora has achieved profitability and free cash flow positive status, supported by a portfolio of premium brands, GMP-certified facilities, and a growing presence in Europe, Australia, and beyond[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACB Holding.